Learn about an FDA-approved treatment for IgA Nepropathy- Tarpeyo

Поделиться
HTML-код
  • Опубликовано: 12 сен 2024
  • Learn about an FDA-approved treatment proven to reduce the loss of kidney function in adult patients with IgA Nephropathy (IgAN)
    Listen to this presentation from Dr. Sayna Norouzi.
    This webinar will cover:
    • A new indication and what this may mean for you
    •How this product is different from others for IgAN
    • Hear a patient’s perspective

Комментарии • 6

  • @Maurya88888
    @Maurya88888 3 месяца назад

    good

  • @SaddamHussain-ef4vf
    @SaddamHussain-ef4vf 2 месяца назад

    More guide i like to get from you

  • @gabrielasanchez919
    @gabrielasanchez919 Месяц назад

    There's not too many reviews from patients regarding this medication that's why I'm so scared to start this medication 😢

  • @gabrielasanchez919
    @gabrielasanchez919 Месяц назад

    Can someone please help and answer my questions my doctor only gets me confused

  • @gabrielasanchez919
    @gabrielasanchez919 Месяц назад

    I'm barely going to start this medication soon in 3 days but, plan to have a surgery on December 2024. So what can I do, do I stop the medication or do I do not take it at all . And yes my biggest fear is to have moon face and weight gain 😥.... I'm stage 3 on my kidneys disease 😢

  • @fifanguyen1787
    @fifanguyen1787 5 месяцев назад

    Can we engineer the genes of probiotics so that they can produce enzymes to neutralize IgA1 in the gut, similar to how Tarpeyo works?